The Board of Directors of TTK Healthcare Ltd (TTKHLTCARE) at its meeting held on May 27, 2021 has declared Final Dividend of Rs 6 per equity share for financial year 2020-21. The meeting of the Board of Directors was held through video conferencing which commenced at 11.30 a.m. and concluded at 1.00 p.m.
TTK Healthcare Ltd Q4 Result
The company has reported total income of Rs. 184.66 crores for the period Q4 FY20-21 as compared to Rs. 181.72 crores for the period Q3 FY20-21. Further, it has posted net profit of Rs.10.34 crores for the period ended March 31, 2021 as against net profit of Rs.7.68 crores for the period ended December 31, 2020.
Similar Posts
- TPL Plastech Ltd Declares Final Dividend of Rs 3.5
- Dalmia Bharat Sugar & Industries Declares Final Dividend of Rs 3
TTK Healthcare Ltd Dividend Record Date
The company in its letter informed the exchanges that it has fixed (…) as the Record date. The final dividend, subject to the approval of the Members at the 63rd AGM, will be paid to eligible Members who hold shares as on record date.
To receive dividend, you must have shares in your demat account on record date. Hence, you should buy shares before ex-dividend date. Note – In other words, if you buy shares on ex-dividend date, you will not be eligible to receive dividend. Bookmark our website for latest and upcoming dividend announced by companies in 2021.
Moreover, here is the copy of statement, the company has sent to the exchanges:
We would like to inform you that the Board of Directors in their meeting held today, inter alia considered and approved Dividend of Rs. 6/- per Equity Share of Rs. 10/- each (60%), for the financial year ended 31st March, 2021.
Important Dates
- Company – TTK Healthcare Ltd
- Script Name – TTKHLTCARE (NSE) and 507747 (BSE)
- Dividend Amount – 6 Rs Per Share
- Dividend Type – Final
- Ex-Dividend Date – NA
- Record Date – NA
- Payment Date – Within 21 days
Also, you can find more information about TTK Healthcare Ltd on National Stock Exchange and Moneycontrol – TTK Healthcare Ltd has three Strategic Business Units Pharmaceuticals Division, Consumer Products Division and Biomedical Devices Division.
